CDC releases COVID-19 guidance for those with health conditions
The Centers for Disease Control and Prevention (CDC) said those with preexisting health conditions are more at risk of severe illness if they contract COVID-19. Read More »
The Centers for Disease Control and Prevention (CDC) said those with preexisting health conditions are more at risk of severe illness if they contract COVID-19. Read More »
The U.S. Food and Drug Administration (FDA) recently issued the first emergency use authorization (EUA) allowing the Pfizer-BioNTech COVID-19 vaccine to be distributed in the U.S., according to a release by the FDA. Read More »
The U.S. Food and Drug Administration (FDA) approved the first drug to be used for positron emissions tomography (PET) imaging for prostate cancer on Dec. 1. Read More »
Researchers recently dove into the complex answer behind the question of whether or not the United States or China holds more influence in the Indo-Pacific Region, according to a research brief from the RAND Corporation. Read More »
Amazon has now launched an online pharmacy to serve as competition for other big-named retail pharmacies, according to a news release. Read More »
The Food and Drug Administration (FDA) confirmed that all dispensers such as pharmacies will have to meet requirements that go into effect on Friday, Nov. 27, regardless of the American Pharmacists Association's (APhA) concerns that not all of the Drug Supply Chain Security Act requirements are undermined by COVID-19 pandemic responses. Read More »
The U.S. Food and Drug Administration (FDA) approved the over-the-counter (OTC) use of a lotion designed to treat head lice. Read More »
The U.S. Food and Drug Administration (FDA) recently released a warning for pregnant mothers regarding a family of medications that includes ibuprofen, naproxen, diclofenac, celecoxib and other nonsteroidal anti-inflammatory drugs (NSAIDs). Read More »
The National Institute of Health (NIH) has recently expanded options for pharmacists to engage in their Loan Repayment Programs (LRPs), and can apply by Friday, Nov. 20 for this year’s programs. Read More »
The U.S. Food and Drug Administration (FDA) announced the approval of Opdivo (nivolumab) combined with Yervoy (ipilimumab) for first-line treatment of adults who have malignant pleural mesothelioma that cannot use alternative methods for removal such as surgery. Read More »
The U.S. Food and Drug Administration (FDA) recently approved Pfizer’s drug XELJANZ (tofacitinib) for treatment of polyarticular course juvenile idiopathic arthritis (pcJIA). Read More »
Eli Lilly and Company’s phase 3 monarchE trial of their cancer treatment drug Verzenio® (abemaciclib) has demonstrated a significant decrease risk of breast cancer recurrence for patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) high risk early breast cancer. Read More »
The American Society of Health-System Pharmacists (ASHP) recently released a response to a petition calling for an end to gender inequality in the clinical pharmacy industry. Read More »
Dan Leonard formerly president and CEO of the National Pharmaceutical Council (NPC) has been named new president and CEO of the Association for Accessible Medicines, members of the AAM board announced on Aug. 25. Read More »
This year's We Work for Health Champion Awards honors many individuals that have done tremendous work in the health care industry this year, especially with COVID-19 presenting a new and unique situation. Read More »
The high costs of medical care are well-documented, but those battling significant illnesses have found a measure of economic relief through manufacturer cost-sharing assistance programs. Read More »
The push for a COVID-19 vaccine is “remarkably positioned to succeed,” Jenny Bryant, executive vice president of policy and research for the Pharmaceutical Research and Manufacturers of America (PhRMA), said. Read More »
A recent letter to Congressional leaders from a coalition headed by the National Forum for Heart Disease and Stroke Prevention urges Congress to include payments for front-line pharmacists in the next COVID-19 relief package by designating them as providers under Medicare Part B. Read More »
James Capretta, a resident fellow and health analyst with the American Enterprise Institute (AEI), a Washington D.C.-based think tank that researches government, economics and social welfare, called for a coordinated effort to distribute vaccine worldwide to prevent COVID-19 infection. Read More »
The majority receiving COVID-19 experimental treatments are those patients hospitalized with the coronavirus, Cedars-Sinai Hospital Epidemiology Director Jonathan Grein said in a recent news release. Read More »